Recursion Pharmaceuticals, Inc. Class A Common Stock
Updated: Oct 30, 2026, 2:17 AM
Open RXRX on TradingViewAffiliate linkRecursion Pharmaceuticals, Inc. Class A Common Stock
Price history is not tracked for this symbol · Oct 30, 2026
Position vs 200-day MA
+20.1% above 200-day MA
RXRX is 20.1% above its 200-day MA for 9 days and outranks most of Healthcare stocks, at the top 18%. That looks like genuine relative strength.
Price
$4.24
200-day MA
$3.53
Streak above
9 days
Avg volume (90d)
22.4M
Market cap
$2.6B
RXRX is above its 200-day average, but fewer Healthcare stocks are confirming the trend.
Healthcare
36%
310 of 855 stocks
S&P 500
63%
316 of 498 stocks
This stock is currently above its 200-day average. The comparison shows how much support the move has around it.